OAM
ACHN

Oxford Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Oxford Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-601,375
Closed -$2.17M – 2257
2019
Q3 		$2.17M Sell
601,375
-360,564
-37% -$1.39M 0.05% 492
2019
Q2 		$2.58M Buy
961,939
+11,470
+1% +$33.9K 0.06% 529
2019
Q1 		$2.81M Sell
950,469
-364,208
-28% -$895K 0.06% 424
2018
Q4 		$2.09M Buy
1,314,677
+710,639
+118% +$2.01M 0.05% 446
2018
Q3 		$2.22M Buy
604,038
+336,376
+126% +$1M 0.05% 608
2018
Q2 		$761K Buy
267,662
+48,673
+22% +$166K 0.01% 1167
2018
Q1 		$812K Sell
218,989
-143,633
-40% -$470K 0.02% 1032
2017
Q4 		$1.07M Buy
362,622
+335,529
+1,238% +$1.22M 0.02% 899
2017
Q3 		$121K Sell
27,093
-64,691
-70% -$287K ﹤0.01% 1468
2017
Q2 		$421K Buy
+91,784
New +$369K 0.01% 1163
2017
Q1 		– Sell
-210,165
Closed -$868K – 1526
2016
Q4 		$868K Sell
210,165
-595,802
-74% -$3.17M 0.03% 501
2016
Q3 		$6.53M Buy
+805,967
New +$6.85M 0.2% 118
2016
Q2 		– Sell
-608,481
Closed -$4.7M – 922
2016
Q1 		$4.7M Sell
608,481
-240,698
-28% -$1.76M 0.13% 174
2015
Q4 		$9.17M Buy
849,179
+25,990
+3% +$236K 0.22% 85
2015
Q3 		$5.69M Buy
823,189
+412,812
+101% +$3.36M 0.18% 105
2015
Q2 		$3.64M Sell
410,377
-214,702
-34% -$2.03M 0.1% 228
2015
Q1 		$6.16M Buy
625,079
+190,626
+44% +$2.38M 0.16% 154
2014
Q4 		$5.33M Buy
434,453
+254,945
+142% +$3.11M 0.12% 189
2014
Q3 		$1.81M Buy
+179,508
New +$1.67M 0.04% 390
2013
Q3 		– Sell
-504,861
Closed -$4.13M – 962
2013
Q2 		$4.13M Buy
+504,861
New +$3.85M 0.11% 301

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oxford Asset Management's ACHN Position: Q4 2019 in Review

Oxford Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 601,375 shares — an estimated $2.17M sold.

Oxford Asset Management first reported a position in ACHN in Q2 2013 and held it in 20 quarters. The position peaked at $9.17M in Q4 2015. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Oxford Asset Management reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 601,375 Achillion Pharmaceuticals shares in Q4 2019, an estimated $2.17M.
  • Oxford Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Oxford Asset Management's Achillion Pharmaceuticals position peaked at $9.17M in Q4 2015.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.